Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.

Authors:
Omar M Shaaban Mohammed K Ali Ali Mohamed A Sabra Diaa Eldeen M Abd El Aal

Contraception 2015 Oct 10;92(4):301-7. Epub 2015 Jun 10.

Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Egypt.

Introduction: This study compares the efficacy of a levonorgestrel-releasing intrauterine system (LNG-IUS) and a low-dose combined oral contraceptive (COC) in reducing adenomyosis-related pain and bleeding.

Materials And Methods: A randomized clinical trial included 62 participants complaining of pain and bleeding that was associated with adenomyosis. Participants were randomly assigned to either LNG-IUS or COC treatment. The outcomes included the improvement of pain using a visual analogue scale, menstrual blood loss using a menstrual diary and estimated uterine volume by ultrasound for 6 months of treatment. We also compared uterine arteries and intramyometrial Doppler indices before and 6 months after treatment with both LNG-IUS and COCs.

Results: Both treatments significantly reduced pain after 6 months of use; however, the reduction was greater in the LNG-IUS group (from 6.23±0.67 to 1.68±1.25) compared with the COCs group (from 6.55±0.68 to 3.90±0.54). Both treatment arms significantly decreased the number of bleeding days, uterine volume and Doppler blood flow in the uterus from before to after treatment. These effects were more significant in the LNG-IUS arm compared with the COC arm.

Conclusion: Both LNG-IUS and COCs decreased the pain and menstrual bleeding that is associated with adenomyosis. However, LNG-IUS is more effective than the COCs in reducing pain and menstrual blood loss. This effect may be secondary to the decrease in uterine volume and the increase in blood flow resistance.

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.contraception.2015.05.015DOI Listing
October 2015

Publication Analysis

Top Keywords

uterine volume
12
months treatment
8
oral contraceptive
8
pain menstrual
8
clinical trial
8
blood flow
8
bleeding associated
8
associated adenomyosis
8
combined oral
8
randomized clinical
8
blood loss
8
menstrual blood
8
intrauterine system
8
levonorgestrel-releasing intrauterine
8
low-dose combined
8
lng-ius
7
pain
6
treatment
6
pain months
4
reduced pain
4

Keyword Occurance

Similar Publications

Impaired spermatogenesis caused by busulfan is partially ameliorated by treatment with conditioned medium of adipose tissue derived mesenchymal stem cells.

Authors:
Mohammad-Amin Abdollahifar Nahid Azad Maryam Faraji Sani Amir Raoofi Shabnam Abdi Abbas Aliaghaei Hojjat-Allah Abbaszadeh Vahid Ebrahimi Fatemeh Fadaei Fathabadi Faezeh Ghanimat Maryam Movahedi

Biotech Histochem 2021 Apr 11:1-11. Epub 2021 Apr 11.

Student Research Committee, and Faculty of Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Busulfan (BSU) is a chemotherapeutic drug that can cause subfertility or sterility in males. We investigated the effects of adipose tissue-derived mesenchymal stem cells (AT-MSC) conditioned medium (CM) (AT-MSC-CM) on histopathological and molecular characteristics of mouse testes exposed to BSU using stereology. We used adult male mice divided randomly into five groups: control, Dulbecco's modified Eagle's medium (DMEM), dimethyl sulfoxide (DMSO), BSU, and BSU + CM. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Prioritizing Surgical Services during on-Going Pandemic Response: Modification and Reliability of the Medically Necessary Time Sensitive Surgery (MeNTS) Scoring Tool.

Authors:
Erin Saleeby Rachel Acree Cecilia Wieslander Christina Truong Lisa Garcia Sarah Eckhardt Anjali Hari Laila Al-Marayati Lisa Greenwell Christine H Holschneider

J Med Syst 2021 Apr 7;45(5):59. Epub 2021 Apr 7.

David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Health systems are struggling to manage a fluctuating volume of critically ill patients with COVID-19 while continuing to provide basic surgical services and expand capacity to address operative cases delayed by the pandemic. As we move forward through the next phases of the pandemic, we will need a decision-making system that allows us to remain nimble as clinicians to meet our patient's needs while also working with a new framework of healthcare operations. Here, we present our quality improvement process for the adaptation and application of the Medically Necessary Time-Sensitive (MeNTS) toolto gynecologic surgical services beyond the initial COVID response and into recovery of surgical services; with analysis of the reliability of the modified-MeNTS tool in our multi-site safety net hospital network. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

The intraoperative use of internal iliac artery balloon catheters in cesarean deliveries for abnormal invasive placentation: A 3-year retrospective cohort review in Doha, Qatar.

Authors:
Husham A Ahmed Fathima Minisha Isaac A Babarinsa Ahmed J Omar Arabo I Bayo Khalid K Omar Thomas A Farrell

Qatar Med J 2021 15;2021(1). Epub 2021 Mar 15.

Department of Obstetrics and Gynecology, Women's Wellness and Research Center, Hamad Medical Corporation, PO Box 3050, Doha-Qatar E-mail:

Background: Abnormal invasive placentation leads to massive intraoperative hemorrhage and maternal morbidity. This study aimed to assess the impact of the preoperative use of internal iliac artery balloon occlusion (IIABO) catheters in patients who had a cesarean delivery (CD) for invasive placentation, commonly known as the placenta accreta spectrum.

Methods: This retrospective cohort study reviewed 67 pregnancies complicated by abnormal invasive placenta and confirmed intraoperatively. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Multiparametric magnetic resonance imaging facilitates the selection of patients prior to fertility-sparing management of endometrial cancer.

Authors:
Yuki Himoto Yulia Lakhman Shinya Fujii Satoshi Morita Jennifer J Mueller Mario M Leitao Aki Kido

Abdom Radiol (NY) 2021 Apr 7. Epub 2021 Apr 7.

Department of Diagnostic Radiology and Nuclear Medicine, Kyoto University Hospital, Kyoto, Japan.

Purpose: To compare the diagnostic performance of biparametric magnetic resonance imaging (bpMRI) versus multiparametric MRI (mpMRI) for the staging of well-differentiated endometrioid endometrial cancer (EC) in potential candidates for fertility-sparing management.

Methods: This multi-center retrospective study included 48 potential candidates for fertility-sparing management (age <46 years, grade 1 endometroid EC) who did not wish to undergo fertility-sparing management and thus underwent definitive surgery. Two readers (R1, R2) independently reviewed bpMRI (T1, T2, and diffusion-weighted imaging) and mpMRI (bpMRI and dynamic contrast-enhanced imaging, DCE) during two separate sessions spaced one month apart for the presence of myometrial invasion (MI), cervical stromal involvement (CSI), malignant adnexal disease (mAD), and pelvic lymphadenopathy (pLNM). Read More

View Article and Full-Text PDF
April 2021
Similar Publications